| 名稱 | CDKN2A p.L27fs Reference Standard 標(biāo)準(zhǔn)品 |
| 型號(hào) | CBP10458 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | CDKN2A p.L27fs Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- 【靶點(diǎn)模型+診斷質(zhì)控】BCR-ABL1的藥物開發(fā)和診斷
- IL-21藥篩細(xì)胞模型
- 剖析正常細(xì)胞是如何成長為腫瘤細(xì)胞的
- 增強(qiáng)腫瘤免疫療法新靶點(diǎn)：ADORA2B（腺苷A2B受體）
- Nature：繞過Ras激酶“不可成藥性”的抗癌新思路
- OX40&PD-1/L1雙免疫檢查點(diǎn)細(xì)胞篩選模型
- FGFR2融合靶向藥物細(xì)胞篩選模型
- 科學(xué)家有望利用對(duì)療法敏感性的癌細(xì)胞來清除耐藥性癌細(xì)胞
- IDH基因診斷標(biāo)準(zhǔn)品
- 細(xì)胞株的STR鑒定技術(shù)分享
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > Mutation > CBP10458CDKN2A p.L27fs Reference Standard 標(biāo)準(zhǔn)品
- 詳細(xì)內(nèi)容
CBP10458 | |
| Gene | CDKN2A |
| Description | CDKN2A, cyclin-dependent kinase inhibitor 2A, is a tumor suppressor (PMID: 30562755) that encodes p16 and p14ARF from alternate reading frames, which function to inhibit Cdk4 and Cdk6 and regulate Tp53 activity to promote cell-cycle arrest (PMID: 23875803, PMID: 17055429, PMID: 27428416). CDKN2A germline mutations are associated with familial atypical multiple mole melanoma and somatic mutations are highest in pancreatic, HNSCC, NSCLC, and melanoma (PMID: 27283171). |
| Technical Data | |
| DNA Change | c.233_234delTC |
| AA Change | p.L27fs |
| Mutation type | Frame_Shift_Del |
| Zygosity | Homozygous |
| Allelic Frequency | 100.00% |
| Transcript | ENST00000479692.2 |
| Cosmic ID | N/A |
| Chr position(GRCh37) | chr9:21971125_21971124 |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
" _ue_custom_node_="true">
會(huì)員_a.png)